Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Palatin to Report First Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on November 14, 2022

PTN

CRANBURY, N.J., Nov. 9, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2023 operating results on Monday, November 14, 2022, before the open of the U.S. financial markets.

Palatin Technologies, Inc.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 14, 2022, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast

Q1 Fiscal Year 2023 Results Press Release

11/14/2022 at 7:30 a.m. ET

Q1 Fiscal Year 2023 Conference Call-Live

11/14/2022 at 11:00 a.m. ET

US Toll Free Dial-In Number:

1-866-580-3963

International Dial-In Number:

1-786-697-3501

Conference ID:

5980994#

Q1 Fiscal Year 2023 Conference Call-Replay

11/14/2022-11/21/2022

US Toll Free Dial-In Number:

1-866-583-1035

International Dial-In Number:

+44 (0) 20 8196 1480

Replay Passcode:

5980994#

Audio Webcast Live and Replay Access

http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.

About Palatin

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-first-quarter-fiscal-year-2023-results-teleconference-and-webcast-to-be-held-on-november-14-2022-301673700.html

SOURCE Palatin Technologies, Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today